Latest Supply Chains News

American Rare Earths has partnered with Novex to tackle the critical oxide-to-metal bottleneck in the US rare earth supply chain, aiming to establish a fully domestic mine-to-magnet value chain from its Halleck Creek Project.

Viridis Mining and Minerals Limited (ASX: VMM) has halted trading of its shares pending the release of its Definitive Feasibility Study results, with the suspension expected to last until 20 August 2026 or earlier if the announcement is made sooner.

ABx Group secures environmental approvals consultancy for Sunrise Bauxite Project as Good Importing International invests A$2.7 million for a 70% stake. GII's option on NSW assets expires, leaving ABx with full control.

Radiopharm Theranostics is gearing up for a pivotal Phase 3 trial of its brain metastases imaging agent RAD101, following strong Phase 2b results and an upcoming FDA meeting to finalise trial design.

New Hope Group exceeded its FY26 coal production and sales guidance, driven by strong performances at Bengalla and New Acland mines, alongside a notable price uplift amid global supply tightness.

Amcor’s FY2026 results reflect the full impact of its 2025 Berry Global acquisition, with net sales soaring 57% to $23.5 billion and net income more than doubling to $1.1 billion. The company also announced a fiscal year-end change and a raised dividend.

Zicom Group anticipates a significant fall in revenue and profits for FY2026, citing completion of major EPC contracts and geopolitical headwinds, but sees improving prospects with renewed political stability and fresh tenders.

The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.

JB Hi-Fi delivered a solid FY26 with record revenue and profit growth, declaring a 22.5% higher dividend and advancing its net-zero emissions goal.

GWA Group posted modest revenue and earnings growth in FY26, driven by volume gains across Australia, New Zealand, and the UK, while raising dividends and advancing strategic priorities despite challenging market conditions.

Dreadnought Resources has validated significant high-grade tungsten mineralisation at its Mangaroon and Mangaroon South projects in WA, with rock chip assays far exceeding typical global grades. Drilling at the key Nina target is slated for late 2026 or early 2027, while systematic mapping and sampling at Mangaroon South will start in September.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.